Nov
DEC
Jan
21
2014
2015
2016
1 captures
21 Dec 15 - 21 Dec 15
Close
Help
Skip to main content
Access brought to you by:
LOCKSS
Login
Search for this keyword
Advanced Search
Main menu
HOME
BROWSE BY CONFERENCE
BROWSE BY DISCIPLINE
-- All Disciplines --
Anesthesiology
Cardiology & Cardiovascular Medicine
Dentistry
Dermatology
Endocrinology, Diabetes & Metabolism
Emergency Medicine & Critical Care
Hematology
Hepatology
Infectious Diseases
Nephrology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopaedics & Sports Medicine
Psychiatry & Psychology
Pulmonary & Respiratory Medicine
Radiology
Rheumatology
Veterinary Medicine
ABOUT
About Us
International Medical Advisory Board
Reprints
Librarian resources
Contact us
Help
Rheumatoid Arthritis
The Role of Biosimilar and Orphan Drugs in Treating Patients with Rheumatologic Disease
Lower-Dose Etanercept Plus Methotrexate Shows Benefit for Early RA Patients in PRIZE Trial
Investigational Selective JAK1 Inhibitor Improves Measures of Disease Activity in RA
Abatacept and Adalimumab Equally Effective for Rheumatoid Arthritis
CV Risk Persists in RA Patients despite Increased Medication Use for Both
Efficacy Maintained When Transitioning Directly from TNF Inhibitor to Tofacitinib in RA
MOBILITY Part a Hones in on Effective Dosing for Sarilumab in RA
Effective Treatment Strategies for Rheumatoid Arthritis
Initial Triple Therapy Superior to Monotherapy on Measures of Disease Activity in RA
Experts Debate Triple Therapy versus Biologics as Treatment for RA
Pages
Previous
Next
1
2
3